Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT05137782
Official study title

The Science of the Art of Palliative Care

Study summary

This feasibility pilot study is designed to learn whether patients and their care partners (e.g., family members) are willing and able to complete two study visits at Dartmouth College while receiving cancer care at Dartmouth-Hitchcock Medical Center.

Ask AI to explain this study
Start here

Key things to know

Main goalHealth Services Research

This describes the study’s primary purpose.

What is being studiedSpecialty Palliative Care

The study team can explain what participation involves.

Who it may be forGastrointestinal Cancer · Lung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jan 30, 2024 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Dartmouth-Hitchcock Medical Center

Study sponsor

01
Study overview

What this study is about

Purpose
Health Services Research
Study type
Interventional
Phase
Not applicable
Sponsor
Dartmouth-Hitchcock Medical Center
Interventions being studied
Other: Specialty Palliative Care
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Supportive or behavioral care→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • 18 years or older
  • Patient: has received a diagnosis of advanced lung or gastrointestinal cancer within the last 24 weeks (note: advanced GI cancer will likely be pancreatic or colorectal)
  • Care partner: care partner of a patient who has received a diagnosis of metastatic lung or gastrointestinal cancer who has provided consent for study (either with our without functional MRI study visits)
  • Be able to understand study requirements and make an informed decision to participate
  • Be able to speak and read English
Reasons someone may not be able to joinExclusion criteria
  • Life expectancy of \<8 weeks
  • Known brain metastases
  • Claustrophobia
  • Both patient and care partner refuse to participate in fMRI scan (ie., either patient or care partner must agree to an fMRI scan in order for either to participate)
  • Contraindications to MRI (e.g.: implanted or embedded metal/metal fragments. Metals in the body make the participant unable to undergo an MRI which makes them ineligible for study participation).

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Dartmouth-Hitchcock Medical CenterLebanon, New Hampshire

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jan 30, 2024. Always confirm current availability with the study team.

View original record ↗